INSMED INC (INSM)

Every figure this model derived for INSM, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 28,746,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,160,312,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,633,919,000 AssetsCurrent 2026-06-30
current liabilities 438,744,000 LiabilitiesCurrent 2026-06-30
equity 757,494,000 StockholdersEquity 2026-06-30
interest expense 81,336,000 InterestExpenseNonoperating 2026-06-30
ocf -778,923,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,137,635,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 157,480,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up INSM on one particular measure came for.

RatioValue
cash operating margin-58.98
current ratio3.72
current ratio reported3.72
deferred revenue growth-100.0
dilution pct21.33
fcf margin-71.0
growth cv0.6
interest cover-10.34
operating margin-73.89
owner earnings margin-84.84
revenue growth185.76
revenue growth per share135.52
roic-399.11
rule of 40111.87
sbc pct revenue13.84

What to be careful about

What this model itself distrusts about INSM's figures. Written by the derivation as it ran, not added afterwards.